Results: 104 news stories
For decades, scientists have studied antibiotic resistance, which is how bacteria evolve mechanisms to evade lifesaving drugs. Now, researchers are warning that a similar challenge is emerging among fungi, where resistance to frontline antifungal medications is making serious infections increasingly difficult to treat. Nathan Wiederhold, PharmD, director of the Fungus Testing Laboratory and professor […]
For Anthony Robert Francis, who leads the Office of Innovation and Strategic Partnerships at The University of Texas at San Antonio, commercialization begins with a different question: not whether an innovation or discovery has intellectual property protection, but whether there is a market for the idea. “We have a fairly unusual process inasmuch as […]
Researchers at The University of Texas at San Antonio (UT San Antonio) have uncovered a treasure trove of information about hundreds of proteins released by the liver and how the timing of their release may affect bodily processes. A recent study, published June 2 in Nature Communications, describes how the liver releases certain proteins at […]
Teaming with UF, UCSF and VCU to improve detection, bring hope The Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases at °®ÎÛ´«Ã½, the academic health center of The University of Texas at San Antonio, has received a competitive $2.5 million award to launch and lead a national, multi-site study focused on improving detection and diagnosis […]
Scientists at The University of Texas at San Antonio discovered a potential path to maintaining the cancer-fighting benefits of one type of immunotherapy while limiting harmful organ damage, providing new hope for this promising treatment.
°®ÎÛ´«Ã½, The University of Texas at San Antonio’s academic health center, has been recognized as one of the nation’s top 10 institutions for entrepreneurial readiness, ranking No. 7 in the inaugural Cure Innovation Index for how effectively it helps researchers translate scientific discovery into real-world impact through biomedical innovation and commercialization. […]
Findings could signal early neurodegenerative processes at work Regularly sleeping long hours each night is associated with higher levels of an Alzheimer’s-related protein in the blood, even accounting for other health factors, suggests a new study from °®ÎÛ´«Ã½, the academic health center of The University of Texas at San Antonio. Modeling across a sample […]
University researchers have collaborated to develop three devices that would offer combat medics a suction solution for any setting, from controlled to chaotic. Suction devices remove blood and vomit that can block a wounded patient’s airway and prevent breathing.
Each summer, °®ÎÛ´«Ã½, the academic health center of The University of Texas at San Antonio, welcomes undergraduate students from colleges and universities nationwide who competed for an opportunity to participate in its Summer Physiology Undergraduate Researcher Program and the Summer Undergraduate Research Fellowship.
The American Cancer Society has awarded an $879,000 Research Scholar Grant to Panneerdoss Subbarayalu, PhD, assistant professor/research at The University of Texas at San Antonio. The four-year grant will support groundbreaking research at Greehey Children’s Cancer Research Institute to develop a new targeted therapy for osteosarcoma, the most common type of bone cancer in children and adolescents.
Amelie G. Ramirez, DrPH, MPH, to work with Hispanics in South Texas Content provided by Cliff Despres Amelie G. Ramirez, DrPH, MPH, a cancer researcher at °®ÎÛ´«Ã½, the academic health center of The University of Texas at San Antonio, is receiving a two-year, $400,000 leadership grant from Susan G. Komen to study cancer survivorship. She aims […]
Colton Frisco Jones, MD, a 2nd-year fellow at the Joe R. and Teresa Lozano Long School of Medicine at °®ÎÛ´«Ã½, the academic health center of The University of Texas at San Antonio (UT San Antonio), recently earned the prestigious Healio NextGen Disruptor Award at the American Society of Clinical Oncology (ASCO) 2026 annual […]
A scientist at The University of Texas at San Antonio was recently awarded two grants totaling more than $4.6 million from the National Institutes of Health to study how cells repair DNA to protect the genome, the set of genetic instructions within our cells.
In a study published April 13 in Nature Communications, scientists at The University of Texas at San Antonio found a link between a bacterium in the gut microbiome and lupus, which could lead to more effective treatment of the disease.
A third-year MD/PhD graduate student from The University of Texas at San Antonio (UT San Antonio), Christopher Mullally, recently received funding from the National Institutes of Health National Cancer Institute for a project examining how the body regulates internal sources of mutation and how breakdowns in that regulation may contribute to cancer development. While […]
UT San Antonio now ranks in the top 13%, placing 296 out of 2,250 institutions worldwide. UT San Antonio’s research enterprise is recognized as a globally competitive leader in clinical and academic research, innovation and impact.
San Antonio Report: UT San Antonio lands millions in new state funding
The University of Texas at San Antonio and its academic health center, °®ÎÛ´«Ã½, recently received over $2.7 million in new academic and prevention awards from the Cancer Prevention and Research Institute of Texas (CPRIT) to further its mission of combating cancers across South Texas. Since 2010, CPRIT has awarded the newly integrated UT San Antonio almost $186 million.
The University of Texas System Board of Regents has authorized approximately $470 million in capital investments supporting UT San Antonio’s continued growth as one of the nation’s fastest-rising public research universities and academic health institutions.
For decades, Alzheimer’s disease research has focused almost exclusively on harmful proteins in the brain. But scientists at The University of Texas at San Antonio are taking a new approach to how the disease is understood and treated.